Cargando…
The pharmacological development of direct acting agents for emerging needed therapy against severe acute respiratory syndrome coronavirus-2
Recently, the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) was quickly identified as the causal pathogen leading to the outbreak of SARS-like illness all over the world. As the SARS-CoV-2 infection pandemic proceeds, many efforts are being dedicated to the development of diverse trea...
Autores principales: | Wang, Sheng-Fan, Chen, Kuan-Hsuan, Wang, Szu-Yu, Yarmishyn, Aliaksandr A., Lai, Wei-Yi, Lin, Yi-Ying, Wang, Mong-Lien, Chou, Shih-Jie, Yang, Yi-Ping, Chang, Yuh-Lih |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7493775/ https://www.ncbi.nlm.nih.gov/pubmed/32433345 http://dx.doi.org/10.1097/JCMA.0000000000000353 |
Ejemplares similares
-
Pharmacological development of the potential adjuvant therapeutic agents against coronavirus disease 2019
por: Chen, Kuan-Hsuan, et al.
Publicado: (2020) -
Generation of GLA-Knockout Human Embryonic Stem Cell Lines to Model Autophagic Dysfunction and Exosome Secretion in Fabry Disease-Associated Hypertrophic Cardiomyopathy
por: Song, Hui-Yung, et al.
Publicado: (2019) -
A Review of SARS-CoV-2 and the Ongoing Clinical Trials
por: Tu, Yung-Fang, et al.
Publicado: (2020) -
Highlight of Immune Pathogenic Response and Hematopathologic Effect in SARS-CoV, MERS-CoV, and SARS-Cov-2 Infection
por: Liang, Yanwen, et al.
Publicado: (2020) -
Musashi-1 promotes cancer stem cell properties of glioblastoma cells via upregulation of YTHDF1
por: Yarmishyn, Aliaksandr A., et al.
Publicado: (2020)